The 'Buffy the Vampire Slayer' and 'Gossip Girl' alum, Michelle Trachtenberg, has passed away at age 39. The actress was ...

"My interest in NAFLD started with a close friend's grandfather when he was diagnosed with liver cancer. He had never even ...

Alcoholic and non-alcoholic fatty liver disease (NAFLD) are well-known risk factors for colorectal cancer (CRC).

The global human liver model market, valued at $1.34 billion in 2024, is projected to grow at a CAGR of 14.04% through 2030, ...

Discover the 7 major risk factors for liver cancer, from viral hepatitis to genetics. Learn how lifestyle changes and early ...

At 2 years, participants in the compensated MASH cirrhosis treatment arm of the MAESTRO-NAFLD-1 trial experienced a ...

A study by University of Hyderabad scientists Prof. Kalyankar Mahadev and Prof. C T Anitha, along with their research ...

GLP-1 Receptor Agonist Market. The global GLP-1 receptor agonist market is on the verge of unprecedented growth, fueled by ...

Madrigal's Rezdiffra showed significant liver stiffness reduction in MASH cirrhosis. The company also beat Q4 earnings and ...

Madrigal Pharmaceuticals (MDGL) reported Q4 results and provided a 2-year update from the open-label metabolic dysfunction-associated ...

Madrigal Pharmaceuticals, Inc.'s Rezdiffra, the first approved drug for MASH, showed strong sales growth, with Q4 net sales ...